News

Researchers have discovered why people with a variation of the FTO gene that affects one in six of the population are 70 per cent more likely to become obese.

Long-term collaboration is aimed at developing, obtaining regulatory approval and commercializing companion diagnostics for selected Merck Serono drug development programs.

OGT provides insight into choice of NGS methods.

The agreement will see RIKEN GENESIS become sole distributor of Horizon’s molecular reference standards in Japan.

Agreement covers distribution of Horizon Diagnostics’ molecular reference standards products in Japan.

Luminex submits xTAG® CYP2C19 kit to FDA for review.

A new £10M Innovation and Knowledge Centre (IKC) will boost the UK's ability to translate the emerging field of synthetic biology into application.

48 Companies join forces with the European Commission to set up a Public-Private Partnership and accelerate the deployment of biobased products in Europe.

4SC AG announced that the company has significantly expanded international patent protection for 4SC-202 in the USA, China and Hong Kong.

A charcoal made from biomass could hold the key to re-claiming thousands of square kilometres of polluted ‘brownfield’ land across the world.